Remission and clinical response to open label adalimumab over one year in patients with Crohn´s disease | Charles Explorer

Remission and clinical response to open label adalimumab over one year in patients with Crohn´s disease

Publikace

Abstrakt

Crohn´s disease, Adalimumab

Osoby